Search for: "Mylan Pharmaceuticals"
Results 661 - 680
of 739
Sorted by Relevance
|
Sort by Date
26 Sep 2022, 4:49 am
Mylan. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
2 Sep 2010, 10:51 am
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
10 Sep 2018, 10:17 am
.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
28 Jun 2007, 10:16 am
Although it is doubtful that the Prohias litigation will ever get anywhere near class certification, these plaintiffs' conduct demonstrates the individualized nature of the inquiry, even in stripped-down consumer fraud litigation.From our perspective Prohias II, gets into even jucier defenses, since it's more specific to the pharmaceutical industry. [read post]
1 Jan 2016, 9:00 am
., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
20 Nov 2014, 4:48 am
” Among S&P 500 companies targeted in the 2015 New York City Funds campaign over multiple “priority issues” are Mylan (pay and governance), Nabors Industries (diversity, pay, and governance), Urban Outfitters (diversity and governance), Cimarex Energy (diversity and fossil fuel), Cabot Oil & Gas(diversity and fossil fuel), and Regeneron Pharmaceuticals (diversity and pay). [read post]
8 Aug 2018, 11:15 pm
Mylan Pharmaceuticals, Inc. [read post]
22 Dec 2016, 9:10 am
In the event that permission is granted, Actavis and Mylan have applied for permission to cross-appeal the findings on validity in relation to claims 10-12. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
23 Aug 2011, 7:27 am
Mylan, Inc., 2011 U.S. [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification (Patent Docs)… [read post]
20 Nov 2016, 5:17 pm
For example, according to Coffee, the drug pricing scandals that have hit Valeant Pharmaceuticals and Mylan N.V. were the result of compensation schemes that as structured “incentivized” the executives at those companies to take risk. [read post]
15 Sep 2016, 4:00 am
Mylan Pharmaceuticals ULC, 2015 FC 125 at paragraph 154, to assist with determining whether a feature was an instruction on how to administer a dosage or an aspect of the dosage form itself for determining whether a claim was patentable subject matter or a method medical treatment. [read post]
12 Jan 2016, 11:39 am
., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
20 Jan 2016, 8:00 am
., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
22 Feb 2008, 6:00 pm
), (Washington State Patent Law Blog), (The IP Factor), (IPBiz), (IP Spotlight), (IP Law360), (Innovationpartners), (IPBiz),US FTC files complaint against Cephalon alleging the company paid four generic drug manufacturers (Ranbaxy, Teva, Mylan and Barr) to delay entry as part of litigation settlements: (IP Law360), (IP Law360), (Spicy IP),GlobalGlobal - GeneralWhat is IP value all about? [read post]
